nsv2781921
- Organism: Homo sapiens
- Study:nstd133 (Redin et al. 2016)
- Variant Type:complex chromosomal rearrangement
- Method Type:Sequencing
- Submitted on:GRCh37 (hg19)
- Variant Calls:2
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:1
- Publication(s):Redin et al. 2016
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 429 SVs from 31 studies. See in: genome view
Overlapping variant regions from other studies: 428 SVs from 31 studies. See in: genome view
Overlapping variant regions from other studies: 398 SVs from 32 studies. See in: genome view
Overlapping variant regions from other studies: 391 SVs from 28 studies. See in: genome view
Overlapping variant regions from other studies: 422 SVs from 31 studies. See in: genome view
Overlapping variant regions from other studies: 422 SVs from 31 studies. See in: genome view
Overlapping variant regions from other studies: 393 SVs from 31 studies. See in: genome view
Overlapping variant regions from other studies: 390 SVs from 28 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
---|---|---|---|---|---|---|---|---|---|---|
nsv2781921 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | Second Pass | NC_000023.11 | ChrX | 52,404,034 | 52,404,034 | + |
nsv2781921 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | Second Pass | NC_000023.11 | ChrX | 52,405,007 | 52,405,007 | - |
nsv2781921 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000023.11 | ChrX | 55,650,976 | 55,650,976 | - |
nsv2781921 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000023.11 | ChrX | 55,653,096 | 55,653,096 | + |
nsv2781921 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000023.10 | ChrX | 52,351,024 | 52,351,024 | - | ||
nsv2781921 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000023.10 | ChrX | 52,351,997 | 52,351,997 | + | ||
nsv2781921 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000023.10 | ChrX | 55,677,409 | 55,677,409 | - | ||
nsv2781921 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000023.10 | ChrX | 55,679,529 | 55,679,529 | + |
Variant Call Information
Variant Call ID | Type | Sample ID | Method | Analysis | ClinVar ID | Other Calls in this Sample and Study |
---|---|---|---|---|---|---|
nssv13660327 | inversion | ROC16 | Sequencing | Split read and paired-end mapping | SCV000320917 | nssv13660328 |
nssv13660328 | inversion | ROC16 | Sequencing | Split read and paired-end mapping | SCV000320917 | nssv13660327 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
nssv13660327 | Remapped | Perfect | NC_000023.11:g.524 04034invNC_000023. 11:g.55650976inv | GRCh38.p12 | Second Pass | NC_000023.11 | ChrX | 52,404,034 | 52,404,034 |
nssv13660328 | Remapped | Perfect | NC_000023.11:g.524 05007invNC_000023. 11:g.55653096inv | GRCh38.p12 | Second Pass | NC_000023.11 | ChrX | 52,405,007 | 52,405,007 |
nssv13660327 | Remapped | Perfect | NC_000023.11:g.524 04034invNC_000023. 11:g.55650976inv | GRCh38.p12 | First Pass | NC_000023.11 | ChrX | 55,650,976 | 55,650,976 |
nssv13660328 | Remapped | Perfect | NC_000023.11:g.524 05007invNC_000023. 11:g.55653096inv | GRCh38.p12 | First Pass | NC_000023.11 | ChrX | 55,653,096 | 55,653,096 |
nssv13660328 | Submitted genomic | [NC_000023.10:g.52 351024inv];[NC_000 023.10:g.55679529i nv] | GRCh37 (hg19) | NC_000023.10 | ChrX | 52,351,024 | 52,351,024 | ||
nssv13660327 | Submitted genomic | [NC_000023.10:g.52 351997inv];[NC_000 023.10:g.55677409i nv] | GRCh37 (hg19) | NC_000023.10 | ChrX | 52,351,997 | 52,351,997 | ||
nssv13660327 | Submitted genomic | [NC_000023.10:g.52 351997inv];[NC_000 023.10:g.55677409i nv] | GRCh37 (hg19) | NC_000023.10 | ChrX | 55,677,409 | 55,677,409 | ||
nssv13660328 | Submitted genomic | [NC_000023.10:g.52 351024inv];[NC_000 023.10:g.55679529i nv] | GRCh37 (hg19) | NC_000023.10 | ChrX | 55,679,529 | 55,679,529 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | Sample ID | HGVS | Type | Clinical Interpretation | ClinVar ID | Gender | Other Calls in this Sample and Study |
---|---|---|---|---|---|---|---|
nssv13660327 | ROC16 | GRCh37: [NC_000023.10:g.52351997inv];[NC_000023.10:g.55677409inv] | inversion | SCV000320917 | Female | nssv13660328 | |
nssv13660328 | ROC16 | GRCh37: [NC_000023.10:g.52351024inv];[NC_000023.10:g.55679529inv] | inversion | SCV000320917 | Female | nssv13660327 |